Analyst Consensus ?
ConsensusHold75 ratings
Bullish3546.7%
Neutral3850.7%
Bearish22.6%
Expedia Group, Inc. · EXPE · FY2024 Q3 · Calendar Q4 2024
Expedia Q3 2024: Guidance Raised as Advertising and Vrbo Improve
Expedia’s Q3 evidence supports a constructive operating trajectory: bookings growth, accelerating advertising, improving Vrbo trends, cost discipline, and raised full-year guidance. The case remains conditional on sustaining advertising momentum, converting investment into marketing leverage, and managing regulatory and travel-demand risks.
Reported After market closeNASDAQConsumer Cyclical
$33.40B market cap
100quality score
Earnings scorecard
Reported versus consensus
Reported EPS
$6.13
Consensus $6.04
EPS surprise
+1.5%
Reported versus consensus
Reported revenue
$4.06B
Consensus $4.11B
Revenue surprise
-1.3%
Reported versus consensus
Market reaction
event-close to next-session close
Stock move
+3.8%
Event window
SPY move
+0.4%
Same window
Abnormal move
+3.4%
Stock minus SPY
Volume
3.0×
Versus trailing sessions
Subsequent drift
+4.8%
Up to 20 sessions
EXPESPY benchmark
Ask FN2 about EXPE FY2024 Q3
Transcript, numbers and history already loaded
Why did EXPE rise 3.8% after beating EPS estimates in FY2024 Q3?What changed in EXPE's guidance and outlook in FY2024 Q3?Give me the bull and bear case for EXPE after FY2024 Q3 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the prior quarter, the supplied analysis shows a stronger outlook: guidance sentiment changed from lowered to raised, Vrbo returned to modest growth, advertising revenue accelerated to 32% growth, and management highlighted expanded supply, AI-enabled conversion tools, and international investment.
Guidance delta
Raised: management increased full-year expectations to approximately 5% bookings growth and higher EBITDA margins.
Key takeaways
- Gross bookings grew 7% year over year, led by lodging, consumer brands, and B2B partnerships.
- Advertising revenue grew 32%, with new video-ad products under testing.
- Vrbo returned to modest growth and added significant urban-focused supply.
- Cost discipline supported margin improvement, while full-year guidance was raised.
- The main watchpoints are marketing leverage, advertising durability, costs, and vacation-rental regulation.
Management priorities
- Expand internationally with market-specific brand investment.
- Add advertising products, including video ads.
- Integrate more Vrbo supply and pursue B2B vacation-rental partnerships.
- Enhance One Key loyalty features across brands and geographies.
- Use AI and platform upgrades to improve conversion and self-service.
Follow EXPE with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$291.72Current
$116Low
$243.08Average
$430High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 20, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Oct 7, 2026 |
| BTIG | Buy | Buy | Maintain | Oct 6, 2026 |
| Truist Securities | Hold | Hold | Maintain | Sep 30, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Aug 24, 2026 |
| Wedbush | Outperform | Outperform | Maintain | Aug 20, 2026 |
| UBS | Neutral | Neutral | Maintain | Aug 12, 2026 |
| TD Cowen | Hold | Hold | Maintain | Aug 7, 2026 |
| Susquehanna | Neutral | Neutral | Maintain | Aug 7, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Aug 6, 2026 |
| Piper Sandler | Neutral | Neutral | Maintain | Aug 6, 2026 |
| Cantor Fitzgerald | Neutral | Neutral | Maintain | Aug 6, 2026 |
| Benchmark | Buy | Buy | Maintain | Aug 6, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Aug 6, 2026 |
| B. Riley Securities | Buy | Buy | Maintain | Aug 6, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Jul 30, 2026 |
| Baird | Outperform | Outperform | Maintain | Jul 22, 2026 |
| Jefferies | Buy | Buy | Maintain | Jul 14, 2026 |
| Argus Research | Buy | Buy | Maintain | Jul 7, 2026 |
| DA Davidson | Neutral | Neutral | Maintain | May 18, 2026 |
| Mizuho | Neutral | Neutral | Maintain | Mar 3, 2026 |
| Citizens | Market Perform | Market Perform | Maintain | Feb 17, 2026 |
| BMO Capital | Market Perform | Market Perform | Maintain | Feb 17, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Jan 28, 2026 |
| Bernstein | Market Perform | Market Perform | Maintain | Jan 6, 2026 |
| B of A Securities | Buy | Buy | Maintain | Dec 19, 2025 |
| Citigroup | Neutral | Neutral | Maintain | Nov 11, 2025 |
| JP Morgan | Neutral | Neutral | Maintain | Nov 7, 2025 |
| Oppenheimer | Outperform | Outperform | Maintain | May 9, 2025 |
| JMP Securities | Market Perform | Market Perform | Maintain | Feb 7, 2025 |
| HSBC | Hold | Hold | Maintain | May 7, 2024 |
| Ascendiant Capital | Buy | Buy | Maintain | Dec 29, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Aug 4, 2023 |
| Gordon Haskett | Buy | Hold | Upgrade | May 16, 2023 |
| Wolfe Research | Underperform | Peer Perform | Downgrade | Dec 7, 2022 |
| Redburn Partners | Neutral | Buy | Downgrade | Aug 29, 2022 |
| Deutsche Bank | Buy | Buy | Maintain | Aug 1, 2022 |
| Cowen & Co. | Outperform | Outperform | Maintain | Feb 7, 2022 |
| Stifel | Hold | Hold | Maintain | Nov 8, 2021 |
| Atlantic Equities | Neutral | Overweight | Downgrade | Nov 2, 2021 |
| CFRA | Hold | Hold | Maintain | May 21, 2020 |
| Raymond James | Outperform | Outperform | Maintain | Apr 29, 2020 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Apr 13, 2020 |
| Consumer Edge Research | Equal Weight | Equal Weight | Maintain | Nov 18, 2019 |
| Stifel Nicolaus | Hold | Hold | Maintain | Nov 7, 2019 |
| Piper Jaffray | Neutral | Overweight | Downgrade | Nov 7, 2019 |
| Bank of America | Neutral | Buy | Downgrade | Nov 7, 2019 |
| Argus | Buy | Hold | Upgrade | Jul 31, 2019 |
| Telsey Advisory Group | Perform | Market Perform | Maintain | Nov 29, 2018 |
| PiperJaffray | Overweight | Overweight | Maintain | Jul 27, 2018 |
| Keybanc | Overweight | Overweight | Maintain | Jul 27, 2018 |
| Macquarie | Neutral | Outperform | Downgrade | Mar 15, 2018 |
| MKM Partners | Neutral | Neutral | Maintain | Feb 21, 2018 |
| Needham | Buy | Buy | Maintain | Jan 4, 2017 |
| CLSA | Outperform | Outperform | Maintain | Dec 8, 2016 |
| Pacific Crest | Overweight | Sector Weight | Upgrade | Oct 19, 2016 |
| MoffettNathanson | Buy | Buy | Maintain | Mar 17, 2016 |
| Moffett Nathanson | Buy | Buy | Maintain | Mar 17, 2016 |
| Brean Capital | Buy | Buy | Maintain | Mar 10, 2016 |
| Nomura | Neutral | Neutral | Maintain | Feb 11, 2016 |
| William Blair | Market Perform | Outperform | Downgrade | Nov 5, 2015 |
| Canaccord Genuity | Buy | Buy | Maintain | Sep 17, 2015 |
| Guggenheim | Buy | Buy | Maintain | May 19, 2015 |
| Buckingham Research | Neutral | Neutral | Maintain | Jun 27, 2014 |
| Exane BNP Paribas | Outperform | Outperform | Maintain | Jun 11, 2014 |
| Standpoint Research | Hold | Buy | Downgrade | Oct 31, 2013 |
| FBR Capital | Outperform | Outperform | Maintain | Oct 23, 2013 |
| Janney Capital | Neutral | Neutral | Maintain | Sep 12, 2013 |
| Lazard | Buy | Neutral | Upgrade | Sep 9, 2013 |
| Oddo Securities | Buy | Buy | Maintain | Jul 2, 2013 |
| Ameriprise Financial | Sell | Buy | Downgrade | May 30, 2013 |
| Monness, Crespi, Hardt | Neutral | Buy | Downgrade | Feb 4, 2013 |
| Monness Crespi Hardt | Neutral | Buy | Downgrade | Feb 4, 2013 |
| Ascendiant | Buy | Buy | Maintain | Jan 23, 2013 |
| JG Capital | Overweight | Overweight | Maintain | Dec 5, 2012 |
| Bank oferica | Neutral | Neutral | Maintain | Apr 27, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $291.72. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Wells Fargo | Ken Gawrelski | $275 | $260.07 | -5.7% | Oct 7, 2026 |
| Truist Financial | Analyst unavailable | $288 | $266.33 | -1.3% | Sep 30, 2026 |
| Morgan Stanley | Matthew Cost | $235 | $293.08 | -19.4% | Sep 16, 2026 |
| BTIG | Analyst unavailable | $400 | $339.12 | +37.1% | Aug 25, 2026 |
| Evercore ISI | Analyst unavailable | $430 | $331.15 | +47.4% | Aug 24, 2026 |
| Wedbush | Analyst unavailable | $417 | $325.47 | +42.9% | Aug 20, 2026 |
| UBS | Lloyd Walmsley | $351 | $321.07 | +20.3% | Aug 12, 2026 |
| BMO Capital | Analyst unavailable | $285 | $306.57 | -2.3% | Aug 7, 2026 |
| Susquehanna | Shyam Patil | $315 | $306.57 | +8.0% | Aug 7, 2026 |
| Goldman Sachs | Eric Sheridan | $370 | $311.96 | +26.8% | Aug 6, 2026 |
| Robert W. Baird | Michael Bellisario | $335 | $311.5 | +14.8% | Aug 6, 2026 |
| Piper Sandler | Analyst unavailable | $325 | $319.08 | +11.4% | Aug 6, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $310 | $319.66 | +6.3% | Aug 6, 2026 |
| BTIG | Analyst unavailable | $350 | $319.66 | +20.0% | Aug 6, 2026 |
| Barclays | Analyst unavailable | $320 | $319.66 | +9.7% | Aug 6, 2026 |
| B.Riley Financial | Naved Khan | $390 | $319.66 | +33.7% | Aug 6, 2026 |
| Evercore ISI | Analyst unavailable | $375 | $319.66 | +28.5% | Aug 6, 2026 |
| Morgan Stanley | Analyst unavailable | $300 | $293.09 | +2.8% | Jul 30, 2026 |
| Robert W. Baird | Analyst unavailable | $294 | $264.94 | +0.8% | Jul 22, 2026 |
| Goldman Sachs | Analyst unavailable | $330 | $267.95 | +13.1% | Jul 20, 2026 |
| Cantor Fitzgerald | Deepak Mathivanan | $255 | $265.01 | -12.6% | Jul 20, 2026 |
| Argus Research | Analyst unavailable | $315 | $271.27 | +8.0% | Jul 7, 2026 |
| Wells Fargo | Analyst unavailable | $303 | $265.28 | +3.9% | Jun 30, 2026 |
| Susquehanna | Analyst unavailable | $250 | $229.98 | -14.3% | May 11, 2026 |
| Barclays | Analyst unavailable | $264 | $229.98 | -9.5% | May 11, 2026 |
| UBS | Stephen Ju | $262 | $236.19 | -10.2% | May 8, 2026 |
| Robert W. Baird | Michael Bellisario | $290 | $252.79 | -0.6% | May 8, 2026 |
| Wells Fargo | Analyst unavailable | $307 | $252.79 | +5.2% | May 8, 2026 |
| Piper Sandler | Analyst unavailable | $245 | $252.79 | -16.0% | May 8, 2026 |
| Cantor Fitzgerald | Deepak Mathivanan | $240 | $251.44 | -17.7% | Apr 27, 2026 |
| Morgan Stanley | Brian Nowak | $290 | $225.81 | -0.6% | Mar 27, 2026 |
| D.A. Davidson | Analyst unavailable | $260 | $200.74 | -10.9% | Feb 17, 2026 |
| Susquehanna | Shyam Patil | $240 | $204.98 | -17.7% | Feb 17, 2026 |
| BMO Capital | Brian Pitz | $255 | $212.67 | -12.6% | Feb 17, 2026 |
| Robert W. Baird | Analyst unavailable | $282 | $213.94 | -3.3% | Feb 13, 2026 |
| Deutsche Bank | Analyst unavailable | $244 | $216.34 | -16.4% | Feb 13, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $245 | $214.92 | -16.0% | Feb 13, 2026 |
| UBS | Analyst unavailable | $266 | $227.24 | -8.8% | Feb 13, 2026 |
| Wells Fargo | Ken Gawrelski | $315 | $227.24 | +8.0% | Feb 13, 2026 |
| Barclays | Analyst unavailable | $260 | $227.24 | -10.9% | Feb 13, 2026 |
| Truist Financial | Gregory Miller | $252 | $246.61 | -13.6% | Feb 10, 2026 |
| Wedbush | Analyst unavailable | $260 | $233.01 | -10.9% | Feb 6, 2026 |
| Goldman Sachs | Analyst unavailable | $325 | $269.49 | +11.4% | Jan 27, 2026 |
| Barclays | Trevor Young | $245 | $272.15 | -16.0% | Jan 21, 2026 |
| UBS | Analyst unavailable | $270 | $295.88 | -7.4% | Jan 13, 2026 |
| Wells Fargo | Analyst unavailable | $329 | $301.31 | +12.8% | Jan 9, 2026 |
| Bernstein | Richard Clarke | $256 | $293.3 | -12.2% | Jan 6, 2026 |
| BTIG | Analyst unavailable | $330 | $287.47 | +13.1% | Jan 6, 2026 |
| Wedbush | Analyst unavailable | $290 | $287.89 | -0.6% | Dec 19, 2025 |
| Jefferies | Analyst unavailable | $285 | $278.78 | -2.3% | Dec 11, 2025 |
| D.A. Davidson | Tom White | $294 | $265.12 | +0.8% | Nov 17, 2025 |
| Mizuho Securities | Lloyd Walmsley | $270 | $263.11 | -7.4% | Nov 14, 2025 |
| Truist Financial | Analyst unavailable | $210 | $218.85 | -28.0% | Oct 27, 2025 |
| Wedbush | Analyst unavailable | $230 | $226.14 | -21.2% | Oct 22, 2025 |
| Jefferies | Analyst unavailable | $220 | $215.58 | -24.6% | Oct 17, 2025 |
| Wells Fargo | Analyst unavailable | $212 | $219.23 | -27.3% | Oct 6, 2025 |
| Susquehanna | Shyam Patil | $200 | $192.63 | -31.4% | Aug 11, 2025 |
| Bernstein | Richard Clarke | $210 | $192.63 | -28.0% | Aug 11, 2025 |
| D.A. Davidson | Tom White | $218 | $195.5 | -25.3% | Aug 11, 2025 |
| Bernstein | Richard Clarke | $215 | $195.26 | -26.3% | Aug 10, 2025 |
| BTIG | Jake Fuller | $250 | $195.26 | -14.3% | Aug 8, 2025 |
| Piper Sandler | Thomas Champion | $190 | $195.26 | -34.9% | Aug 8, 2025 |
| Wells Fargo | Ken Gawrelski | $211 | $195.26 | -27.7% | Aug 8, 2025 |
| Cantor Fitzgerald | Deepak Mathivanan | $200 | $190.73 | -31.4% | Jul 23, 2025 |
| Wells Fargo | Ken Gawrelski | $143 | $137.11 | -51.0% | Apr 7, 2025 |
| Barclays | Trevor Young | $166 | $182.33 | -43.1% | Jan 13, 2025 |
| D.A. Davidson | Tom White | $190 | $130.01 | -34.9% | Nov 18, 2024 |
| Deutsche Bank | Leo Horowitz | $192 | $186.15 | -34.2% | Nov 8, 2024 |
| Evercore ISI | Mark Mahaney | $210 | $186.46 | -28.0% | Nov 8, 2024 |
| Piper Sandler | Ross Sandler | $153 | $187 | -47.6% | Nov 8, 2024 |
| Truist Financial | Greg Miller | $148 | $150.84 | -49.3% | Oct 17, 2024 |
| BTIG | Jake Fuller | $175 | $148.48 | -40.0% | Sep 27, 2024 |
| B.Riley Financial | Naved Khan | $186 | $137.68 | -36.2% | Sep 3, 2024 |
| Argus Research | John Staszak | $155 | $126.89 | -46.9% | Aug 13, 2024 |
| Piper Sandler | Tom Champion | $140 | $127.26 | -52.0% | Aug 9, 2024 |
| Bank of America Securities | Justin Post | $144 | $117.97 | -50.6% | Aug 9, 2024 |
| Jefferies | John Colantuoni | $125 | $116.02 | -57.2% | May 7, 2024 |
| D.A. Davidson | Tom White | $135 | $116.36 | -53.7% | May 6, 2024 |
| Barclays | Ross Sandler | $138 | $115.33 | -52.7% | May 6, 2024 |
| Evercore ISI | Mark Mahaney | $175 | $136.09 | -40.0% | May 3, 2024 |
| Oppenheimer | Jed Kelly | $155 | $136.09 | -46.9% | May 3, 2024 |
| Mizuho Securities | James Lee | $135 | $136.09 | -53.7% | May 3, 2024 |
| Piper Sandler | Thomas Champion | $145 | $136.09 | -50.3% | May 3, 2024 |
| Wells Fargo | Ken Gawrelski | $155 | $137.75 | -46.9% | Apr 1, 2024 |
| Ascendiant | Edward Woo | $160 | $135.74 | -45.2% | Mar 14, 2024 |
| D.A. Davidson | Tom White | $75 | $129.7 | -74.3% | Feb 9, 2024 |
| Credit Suisse | Stephen Ju | $174 | $103.19 | -40.4% | Aug 4, 2023 |
| Wedbush | James Hardiman | $116 | $98.67 | -60.2% | Aug 3, 2023 |
| Barclays | Mario Lu | $124 | $92.63 | -57.5% | Nov 6, 2022 |
| Barclays | Mario Lu | $161 | $106.7 | -44.8% | Aug 24, 2022 |
| Morgan Stanley | Analyst unavailable | $128 | $106.84 | -56.1% | Aug 23, 2022 |
| Deutsche Bank | Lee Horowitz | $130 | $105.65 | -55.4% | Aug 3, 2022 |
| Truist Financial | Naved Khan | $185 | $100.75 | -36.6% | Jul 26, 2022 |
| BTIG | Jake Fuller | $150 | $101.2 | -48.6% | Jun 28, 2022 |
| Truist Financial | Naved Khan | $240 | $106.26 | -17.7% | Jun 14, 2022 |
| Goldman Sachs | Eric Sheridan | $173 | $121.99 | -40.7% | Jun 9, 2022 |
| RBC Capital | Brad Erickson | $185 | $127.79 | -36.6% | May 10, 2022 |
| Credit Suisse | Stephen Ju | $225 | $150.31 | -22.9% | May 3, 2022 |
| D.A. Davidson | Analyst unavailable | $195 | $148.81 | -33.2% | May 3, 2022 |
| Morgan Stanley | Analyst unavailable | $210 | $147.66 | -28.0% | May 3, 2022 |
| Deutsche Bank | Analyst unavailable | $235 | $155.16 | -19.4% | May 3, 2022 |
| Mizuho Securities | Analyst unavailable | $172 | $174.81 | -41.0% | May 3, 2022 |
| Barclays | Analyst unavailable | $229 | $174.81 | -21.5% | May 3, 2022 |
| Piper Sandler | Analyst unavailable | $225 | $174.81 | -22.9% | May 3, 2022 |
| Piper Sandler | Thomas Champion | $225 | $174.81 | -22.9% | May 3, 2022 |
| Barclays | Mario Lu | $229 | $150.31 | -21.5% | May 3, 2022 |
| Jefferies | John Colantuoni | $200 | $150.31 | -31.4% | May 3, 2022 |
| Piper Sandler | Thomas Champion | $225 | $150.31 | -22.9% | May 3, 2022 |
| D.A. Davidson | Tom White | $195 | $150.31 | -33.2% | May 3, 2022 |
| Evercore ISI | Mark Mahaney | $238 | $174.81 | -18.4% | May 2, 2022 |
| Mizuho Securities | James Lee | $172 | $174.81 | -41.0% | May 2, 2022 |
| BTIG | Jake Fuller | $235 | $174.81 | -19.4% | May 2, 2022 |
| BTIG | Jake Fuller | $235 | $174.81 | -19.4% | May 2, 2022 |
| Citigroup | Analyst unavailable | $200 | $190.15 | -31.4% | Apr 20, 2022 |
| Argus Research | John Staszak | $220 | $177.3 | -24.6% | Apr 11, 2022 |
| Deutsche Bank | Leo Horowitz | $218 | $179.31 | -25.3% | Mar 13, 2022 |
| Susquehanna | Shyam Patil | $210 | $197.17 | -28.0% | Feb 14, 2022 |
| Wolfe Research | Deepak Mathivanan | $210 | $192.12 | -28.0% | Feb 11, 2022 |
| Barclays | Mario Lu | $226 | $192.12 | -22.5% | Feb 11, 2022 |
| Truist Financial | Naved Khan | $260 | $192.12 | -10.9% | Feb 11, 2022 |
| Goldman Sachs | Eric Sheridan | $220 | $192.12 | -24.6% | Feb 11, 2022 |
| Benchmark Co. | Daniel Kurnos | $265 | $192.12 | -9.2% | Feb 11, 2022 |
| Piper Sandler | Thomas Champion | $231 | $192.12 | -20.8% | Feb 11, 2022 |
| RBC Capital | Brad Erickson | $200 | $192.12 | -31.4% | Feb 11, 2022 |
| Evercore ISI | Mark Mahaney | $238 | $192.12 | -18.4% | Feb 11, 2022 |
| Wells Fargo | Brian Fitzgerald | $250 | $192.12 | -14.3% | Feb 11, 2022 |
| Stifel Nicolaus | Scott Devitt | $215 | $192.12 | -26.3% | Feb 11, 2022 |
| Jefferies | John Colantuoni | $210 | $192.12 | -28.0% | Feb 11, 2022 |
| UBS | Lloyd Walmsley | $183 | $192.12 | -37.3% | Feb 11, 2022 |
| J.P. Morgan | Doug Anmuth | $216 | $192.12 | -26.0% | Feb 11, 2022 |
| Mizuho Securities | James Lee | $155 | $197.52 | -46.9% | Feb 10, 2022 |
| Cowen & Co. | Kevin Kopelman | $200 | $187.35 | -31.4% | Feb 7, 2022 |
| Stifel Nicolaus | Scott Devitt | $190 | $174.42 | -34.9% | Jan 22, 2022 |
| Piper Sandler | Thomas Champion | $216 | $184.4 | -26.0% | Jan 14, 2022 |
| Atlantic Equities | James Cordwell | $180 | $159.84 | -38.3% | Nov 2, 2021 |
| Gordon Haskett Capital Corporation | Robert Mollins | $168 | $148.89 | -42.4% | Aug 6, 2021 |
Track every rating change on EXPE the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationExpedia Group, Inc. operates as a leading online travel company, serving customers both within the United States and across international markets. The enterprise structures its extensive operations into three primary divisions: Retail, Business-to-Business (B2B), and Trivago. Its comprehensive brand portfolio caters to diverse travel needs. Key retail brands include Brand Expedia, a full-service online travel platform offering localized websites; Hotels.com, specializing in the marketing and distribution of lodging accommodations; and Vrbo, an online marketplace dedicated to alternative accommodation options. Other prominent travel booking websites under its umbrella are Orbitz, Travelocity, and CheapTickets. For the EMEA region, ebookers functions as an online travel agent, presenting travelers with a broad spectrum of choices, while Hotwire provides various travel booking services.…
Historical context
All EXPE earningsLatest beats and misses
Who reports nextBeat on EPS
Missed on EPS
Get the EXPE recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2024-11-10T18:38:36.707185+00:00
- Polygon adjusted daily market bars · 2026-10-20T03:20:42.951457+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-20T03:20:42.948625+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-20. For educational purposes only; not investment advice.